BTREX PLUS, Dietary Supplement 100 Caplets
Recalling firm: Lopez Gonzalez Santana Corporation
Why it was recalled
CGMP Deviations: Presence of damaged tablets
Historical recall record. This is not a new recall announcement. “Terminated” describes the FDA recall process; it does not certify that an individual package is safe. FDA termination date: Jan 20, 2022.
Check your package
Compare the exact product and package details with the label you have.
ProductBTREX PLUS, Dietary Supplement 100 Caplets, UPC 05380930801
FDA code information
Lot #30636, Expiration Date 01/2022
Match the product, package size, and code together. A missing match does not guarantee safety.
Full FDA record and distribution details
Original product description
BTREX PLUS, Dietary Supplement 100 Caplets, UPC 05380930801
Extracted codes and context
| Type | Code / value | Context |
|---|---|---|
| lot | 30636 | Lot #30636, Expiration Date 01/2022 |
Original FDA recall reason
CGMP Deviations: Presence of damaged tablets
Recall details
- Recall number
- F-0665-2021
- Event ID
- 88029
- FDA status
- Terminated
- Initiated
- May 25, 2021
- Reported
- Jun 23, 2021
- Classified
- Jun 11, 2021
- Terminated
- Jan 20, 2022
- Quantity
- 894 bottles
- Location
- Rio Piedras, PR, United States
- Initiation type
- Voluntary: Firm initiated
- Notification
- Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit
Where it was distributed
Domestic distribution only-PR
FDA source record · F-0665-2021
Data updated September 16, 2026. View official FDA data ↗
Follow official FDA and manufacturer guidance.